CN114381083B - Antibacterial and antioxidant hydrogel for corneal contact lens and preparation method thereof - Google Patents
Antibacterial and antioxidant hydrogel for corneal contact lens and preparation method thereof Download PDFInfo
- Publication number
- CN114381083B CN114381083B CN202111549250.7A CN202111549250A CN114381083B CN 114381083 B CN114381083 B CN 114381083B CN 202111549250 A CN202111549250 A CN 202111549250A CN 114381083 B CN114381083 B CN 114381083B
- Authority
- CN
- China
- Prior art keywords
- antibacterial
- hydrogel
- antioxidant
- water
- antioxidant hydrogel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
- C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
- C08J3/075—Macromolecular gels
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
- C08J3/246—Intercrosslinking of at least two polymers
-
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/049—Contact lenses having special fitting or structural features achieved by special materials or material structures
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2333/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2333/24—Homopolymers or copolymers of amides or imides
- C08J2333/26—Homopolymers or copolymers of acrylamide or methacrylamide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2405/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2401/00 or C08J2403/00
- C08J2405/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2433/00—Characterised by the use of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides, or nitriles thereof; Derivatives of such polymers
- C08J2433/24—Homopolymers or copolymers of amides or imides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2497/00—Characterised by the use of lignin-containing materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
技术领域technical field
本发明属于高分子水凝胶技术领域,具体涉及一种角膜接触镜用抗菌抗氧化水凝胶及其制备方法。The invention belongs to the technical field of polymer hydrogel, and in particular relates to an antibacterial and anti-oxidation hydrogel for corneal contact lenses and a preparation method thereof.
背景技术Background technique
细菌性角膜炎是一种因受伤或佩戴隐形眼镜后角膜细菌感染引起的眼部疾病,会导致角膜穿孔和基质损伤等并发症。目前临床一般采用含广谱抗生素的滴眼液治疗细菌性角膜炎。但是受给药方式的限制,抗生素滴眼液的药物利用率低,只有不到5%的药物能够真正到达感染区域。此外,细菌感染通常伴随着免疫系统的炎症和通过活性氧产生的氧化应激损伤。过量的活性氧会导致正常细胞功能受损甚至诱导细胞死亡。Bacterial keratitis is an ocular disorder caused by bacterial infection of the cornea after injury or contact lens wear, leading to complications such as corneal perforation and stromal damage. At present, eye drops containing broad-spectrum antibiotics are generally used clinically to treat bacterial keratitis. However, limited by the way of administration, the drug utilization rate of antibiotic eye drops is low, and less than 5% of the drug can actually reach the infected area. Furthermore, bacterial infection is often accompanied by inflammation of the immune system and oxidative stress damage via reactive oxygen species. Excess ROS can lead to impairment of normal cell function and even induce cell death.
与其他抗菌剂相比,抗菌聚合物对细菌表现出显著的选择性,被认为是下一代杀菌剂。抗菌聚合物根据其抗菌机制可分为两类:接触活性聚合物和释放杀菌剂的聚合物,前者通常带有阳离子电荷,通过与带负电荷的细菌膜相互作用直接抑制细菌生长;后者释放杀菌剂以灭活细菌,例如抗生素或其他强抗微生物活性物质(如金属纳米颗粒)。Antimicrobial polymers exhibit remarkable selectivity for bacteria compared with other antimicrobial agents and are considered as next-generation bactericides. Antibacterial polymers can be divided into two categories according to their antibacterial mechanism: contact-active polymers and polymers that release bactericides. The former usually have cationic charges and directly inhibit bacterial growth by interacting with negatively charged bacterial membranes; the latter release Bactericides to inactivate bacteria, such as antibiotics or other substances with strong antimicrobial activity (such as metal nanoparticles).
水凝胶是由交联的亲水聚合物组成的软材料,因其高含水量、可调的力学性能、良好的生物相容性等被广泛应用于组织工程和医疗领域,如人工关节、角膜接触镜、医用敷料等。水凝胶可作为抗菌聚合物载体装载抗生素或纳米颗粒,进而通过接触或释放杀菌剂来抑制细菌感染,例如,公告号为CN102316832B的专利文献公开的药物缓释性水凝胶角膜接触镜。然而,水凝胶中抗生素的持续药物释放仍不能解决耐药菌产生的问题,并且金属和金属氧化物纳米颗粒对哺乳动物细胞具有高细胞毒性。因此,仅通过接触而不是释放药物或纳米颗粒就能灭活细菌的抗菌材料将更安全可靠。Hydrogel is a soft material composed of cross-linked hydrophilic polymers. Because of its high water content, adjustable mechanical properties, and good biocompatibility, it is widely used in tissue engineering and medical fields, such as artificial joints, Contact lenses, medical dressings, etc. Hydrogel can be used as an antibacterial polymer carrier to load antibiotics or nanoparticles, and then inhibit bacterial infection by contacting or releasing bactericides, for example, the drug slow-release hydrogel contact lens disclosed in the patent document CN102316832B. However, the sustained drug release of antibiotics in hydrogels still cannot solve the problem of drug-resistant bacteria, and metal and metal oxide nanoparticles are highly cytotoxic to mammalian cells. Therefore, antimicrobial materials that can inactivate bacteria only by contact rather than releasing drugs or nanoparticles would be safer and more reliable.
发明内容Contents of the invention
基于现有技术中存在的上述缺点和不足,本发明的目的之一是至少解决现有技术中存在的上述问题之一或多个,换言之,本发明的目的之一是提供满足前述需求之一或多个的一种角膜接触镜用抗菌抗氧化水凝胶及其制备方法。Based on the above-mentioned shortcomings and deficiencies in the prior art, one of the purposes of the present invention is to at least solve one or more of the above-mentioned problems in the prior art. In other words, one of the purposes of the present invention is to provide a One or more antibacterial and antioxidant hydrogels for corneal contact lenses and a preparation method thereof.
为了达到上述发明目的,本发明采用以下技术方案:In order to achieve the above object of the invention, the present invention adopts the following technical solutions:
一种角膜接触镜用抗菌抗氧化水凝胶,以重量百分比计,包括如下组分:An antibacterial and antioxidant hydrogel for contact lenses, by weight percentage, comprising the following components:
丙烯酰胺类单体15~20%,季铵化壳聚糖1~1.5%,交联剂0.01~0.05%,引发剂0.01~0.05%,促进剂0.03~0.08%,余量为水。15-20% of acrylamide monomer, 1-1.5% of quaternized chitosan, 0.01-0.05% of cross-linking agent, 0.01-0.05% of initiator, 0.03-0.08% of accelerator, and the balance is water.
作为优选方案,抗菌抗氧化水凝胶,还包括以重量百分比计的以下组分:单宁酸0.001~1.5%。As a preferred solution, the antibacterial and antioxidant hydrogel further includes the following components in weight percentage: 0.001-1.5% tannic acid.
本发明的角膜接触镜用抗菌抗氧化水凝胶,以聚丙烯酰胺类水凝胶作为基体,通过将季铵化壳聚糖和单宁酸引入聚丙烯酰胺类水凝胶网络中形成新的物理交联键(氢键、π-π相互作用、阳离子-π相互作用)来形成半互穿网络,以增强机械强度。季铵化壳聚糖主要提供抗菌性能,单宁酸主要提供抗氧化性能,二者具有协同性;通过调控体系中各组分的含量,获得一系列具有抗菌抗氧化性能的可用于治疗细菌性角膜炎的水凝胶角膜接触镜。The antibacterial and antioxidant hydrogel for contact lenses of the present invention uses polyacrylamide hydrogel as a matrix, and forms a new polyacrylamide hydrogel network by introducing quaternized chitosan and tannic acid into the polyacrylamide hydrogel network. Physically cross-link bonds (hydrogen bonds, π-π interactions, cation-π interactions) to form semi-interpenetrating networks for enhanced mechanical strength. Quaternized chitosan mainly provides antibacterial properties, and tannic acid mainly provides antioxidant properties, and the two are synergistic; by adjusting the content of each component in the system, a series of antibacterial and antioxidant properties can be used to treat bacterial infections. Hydrogel contact lenses for keratitis.
作为优选方案,所述丙烯酰胺类单体为丙烯酰胺、N-异丙基丙烯酰胺或N,N-双甲基丙烯酰胺。As a preferred solution, the acrylamide monomer is acrylamide, N-isopropylacrylamide or N,N-bismethacrylamide.
作为优选方案,所述季铵化壳聚糖的结构式为:As a preferred version, the structural formula of the quaternized chitosan is:
其中,x/(x+y)为季铵化比例,控制在40~70%。Wherein, x/(x+y) is the quaternization ratio, which is controlled at 40-70%.
作为优选方案,所述交联剂为N,N-亚甲基双丙烯酰胺,所述引发剂为过硫酸钾或过硫酸铵,所述促进剂为N,N,N’,N’-四甲基乙二胺。As a preferred version, the crosslinking agent is N,N-methylenebisacrylamide, the initiator is potassium persulfate or ammonium persulfate, and the accelerator is N,N,N',N'-tetra Methylethylenediamine.
本发明还提供如上方案所述的抗菌抗氧化水凝胶的制备方法,包括以下步骤:The present invention also provides the preparation method of the antibacterial and antioxidant hydrogel as described in the above scheme, comprising the following steps:
(1)将季铵化壳聚糖、丙烯酰胺类单体加入水中,搅拌至完全溶解;之后依次加入引发剂、交联剂、促进剂,搅拌均匀形成反应混合液;(1) Add quaternized chitosan and acrylamide monomers into water, stir until completely dissolved; then add initiator, crosslinking agent, accelerator in turn, stir to form a reaction mixture;
(2)将反应混合液转移至模具中进行自由基聚合反应,反应结束之后将产物从模具中取出,转移至水中使凝胶达到溶胀平衡,得到抗菌抗氧化水凝胶。(2) Transfer the reaction mixture to a mold for free radical polymerization. After the reaction, take the product out of the mold and transfer it to water to make the gel reach a swelling balance to obtain an antibacterial and antioxidant hydrogel.
本发明还提供如上方案所述的抗菌抗氧化水凝胶的制备方法,包括以下步骤:The present invention also provides the preparation method of the antibacterial and antioxidant hydrogel as described in the above scheme, comprising the following steps:
(1)将季铵化壳聚糖、丙烯酰胺类单体加入水中,搅拌至完全溶解;之后依次加入引发剂、交联剂、促进剂,搅拌均匀形成反应混合液;(1) Add quaternized chitosan and acrylamide monomers into water, stir until completely dissolved; then add initiator, crosslinking agent, accelerator in turn, stir to form a reaction mixture;
(2)将反应混合液转移至模具中进行自由基聚合反应,反应结束之后将产物从模具中取出并进行冷冻干燥处理,得到冻干的凝胶;(2) Transfer the reaction mixture to a mold for free radical polymerization, and after the reaction, take the product out of the mold and freeze-dry it to obtain a freeze-dried gel;
(3)将冻干的凝胶浸入pH为2~3的单宁酸水溶液中,浸泡结束之后调节单宁酸水溶液的pH至中性,接着将凝胶转移至水中使凝胶达到溶胀平衡,得到抗菌抗氧化水凝胶。(3) immerse the lyophilized gel in an aqueous tannic acid solution with a pH of 2 to 3, adjust the pH of the aqueous tannic acid solution to neutral after the immersion, and then transfer the gel to water to allow the gel to reach a swelling equilibrium, An antibacterial and antioxidant hydrogel was obtained.
作为优选方案,所述自由基聚合反应的温度为20~35℃,时间为12~36h。As a preferred solution, the temperature of the radical polymerization reaction is 20-35° C., and the time is 12-36 hours.
作为优选方案,所述步骤(3)中,浸泡温度为60~75℃,浸泡时间为10~24h。As a preferred solution, in the step (3), the soaking temperature is 60-75° C., and the soaking time is 10-24 hours.
作为优选方案,所述步骤(3)中,采用盐酸调节单宁酸水溶液的pH至2~3,采用氢氧化钠调节单宁酸水溶液的pH至中性。As a preferred solution, in the step (3), hydrochloric acid is used to adjust the pH of the tannic acid aqueous solution to 2-3, and sodium hydroxide is used to adjust the pH of the tannic acid aqueous solution to neutral.
本发明与现有技术相比,有益效果是:The present invention compares with prior art, beneficial effect is:
(1)本发明的抗菌抗氧化水凝胶具有高透光率以及柔软且坚韧的机械性能,可作为角膜接触镜材料,满足佩戴者的舒适性和安全性要求;(1) The antibacterial and antioxidant hydrogel of the present invention has high light transmittance and soft and tough mechanical properties, and can be used as a contact lens material to meet the comfort and safety requirements of the wearer;
(2)本发明的抗菌抗氧化水凝胶具有优异的抗菌和抗氧化活性,且二者具有协同作用;(2) The antibacterial and antioxidant hydrogel of the present invention has excellent antibacterial and antioxidant activities, and the two have synergistic effects;
(3)本发明的抗菌抗氧化水凝胶,其使用的季铵化壳聚糖以及单宁酸均属于天然生物化合物,原料价廉易得,可大大降低水凝胶制备的成本;(3) The antibacterial and antioxidant hydrogel of the present invention, the quaternized chitosan and tannic acid used in it all belong to natural biological compounds, and the raw materials are cheap and easy to get, which can greatly reduce the cost of hydrogel preparation;
(4)本发明的抗菌抗氧化水凝胶不含抗生素等药物,无耐药性问题;(4) The antibacterial and antioxidant hydrogel of the present invention does not contain drugs such as antibiotics, and has no problem of drug resistance;
(5)本发明的抗菌抗氧化水凝胶具有良好的生物相容性;(5) The antibacterial and antioxidant hydrogel of the present invention has good biocompatibility;
(6)本发明的抗菌抗氧化水凝胶可通过改变各组分含量调节其抗菌抗氧化性能,制备工艺简单、易控。(6) The antibacterial and antioxidative hydrogel of the present invention can adjust its antibacterial and antioxidative properties by changing the content of each component, and the preparation process is simple and easy to control.
附图说明Description of drawings
图1为本发明实施例的抗菌抗氧化水凝胶的合成原理路线图;Fig. 1 is the synthetic principle roadmap of the antibacterial and antioxidant hydrogel of the embodiment of the present invention;
图2为本发明实施例1-5的抗菌抗氧化水凝胶的透光率曲线对比图;Fig. 2 is the comparative figure of light transmittance curve of the antibacterial antioxidation hydrogel of the embodiment of the present invention 1-5;
图3为本发明实施例1-5的抗菌抗氧化水凝胶的拉伸应力-应变曲线对比图;Fig. 3 is the comparison chart of the tensile stress-strain curve of the antibacterial and antioxidative hydrogel of the embodiment of the present invention 1-5;
图4为本发明实施例1-5及对比例1-5的抗菌抗氧化水凝胶的抗氧化性能对比图;Fig. 4 is the comparative figure of the antioxidant performance of the antibacterial and antioxidant hydrogels of Examples 1-5 and Comparative Examples 1-5 of the present invention;
图5为本发明实施例1-5及对比例1-5的抗菌抗氧化水凝胶的抗菌性能对比图;Fig. 5 is the comparison chart of the antibacterial properties of the antibacterial and antioxidant hydrogels of Examples 1-5 and Comparative Examples 1-5 of the present invention;
图6为本发明实施例1-5的抗菌抗氧化水凝胶的细胞毒性对比图。Fig. 6 is a comparison chart of the cytotoxicity of the antibacterial and antioxidant hydrogels of Examples 1-5 of the present invention.
具体实施方式Detailed ways
以下通过具体实施例对本发明的技术方案作进一步解释说明。The technical solutions of the present invention will be further explained below through specific examples.
本发明实施例的抗菌抗氧化水凝胶的制备方法,包括以下步骤:The preparation method of the antibacterial and antioxidant hydrogel of the embodiment of the present invention comprises the following steps:
(1)将季铵化壳聚糖1~1.5wt%、丙烯酰胺类单体15~20wt%加入水中,搅拌至完全溶解;之后依次加入引发剂0.01~0.05wt%、交联剂0.01~0.05wt%、促进剂0.03~0.08wt%,搅拌均匀形成反应混合液;(1) Add 1 to 1.5 wt% of quaternized chitosan and 15 to 20 wt% of acrylamide monomer into water, stir until completely dissolved; then add 0.01 to 0.05 wt% of initiator and 0.01 to 0.05 wt% of crosslinking agent in sequence wt%, accelerator 0.03-0.08wt%, stirring evenly to form a reaction mixture;
(2)将反应混合液转移到模具中,在20~35℃下进行自由基聚合反应,反应时长为12~36h,反应结束后将产物从模具中取出;(2) Transfer the reaction mixture to a mold, and carry out free radical polymerization reaction at 20-35° C., the reaction time is 12-36 hours, and the product is taken out from the mold after the reaction;
(3)将步骤(2)取出的产物进行冷冻干燥处理,得到冻干的凝胶;之后将冻干的凝胶浸泡在用盐酸调节的pH值为2~3的不同浓度的单宁酸(TA)水溶液中,在60~75℃下水浴加热10~24h;(3) The product taken out in step (2) is subjected to freeze-drying treatment to obtain a freeze-dried gel; then the freeze-dried gel is soaked in tannic acid ( TA) in an aqueous solution, heated in a water bath at 60-75°C for 10-24 hours;
(4)水浴加热结束后用氢氧化钠将单宁酸溶液pH值调至中性;(4) After the water-bath heating finishes, the pH value of the tannic acid solution is adjusted to neutrality with sodium hydroxide;
(5)将经过步骤(4)处理之后的凝胶取出,在水中浸泡3天,以除去未反应的丙烯酰胺类单体、季铵化壳聚糖、引发剂、促进剂以及单宁酸,并使得凝胶达到溶胀平衡,得到具有抗菌、抗氧化性能的水凝胶。具体可参考如图1所示的抗菌抗氧化水凝胶的合成原理。(5) taking out the gel after step (4) treatment, soaking in water for 3 days, to remove unreacted acrylamide monomer, quaternized chitosan, initiator, accelerator and tannic acid, And make the gel reach the swelling equilibrium, and obtain the hydrogel with antibacterial and antioxidative properties. For details, please refer to the synthesis principle of the antibacterial and antioxidant hydrogel shown in Fig. 1 .
具体地,季铵化壳聚糖(QCS)结构式为:Specifically, the structural formula of quaternized chitosan (QCS) is:
其中,x/(x+y)为季铵化比例,控制在40~70%。Wherein, x/(x+y) is the quaternization ratio, which is controlled at 40-70%.
丙烯酰胺类单体为丙烯酰胺、N-异丙基丙烯酰胺或N,N-双甲基丙烯酰胺,交联剂为N,N-亚甲基双丙烯酰胺,引发剂为过硫酸钾(KPS)或过硫酸铵(APS),促进剂为N,N,N’,N’-四甲基乙二胺;水的用量为6mL。The acrylamide monomer is acrylamide, N-isopropylacrylamide or N,N-bismethacrylamide, the crosslinking agent is N,N-methylenebisacrylamide, and the initiator is potassium persulfate (KPS ) or ammonium persulfate (APS), the accelerator is N,N,N',N'-tetramethylethylenediamine; the amount of water used is 6mL.
以下通过配料表以及制备参数表对实施例1-9以及对比例1-5的差异进行对比列明,具体的制备工艺可参考上述本发明实施例的抗菌抗氧化水凝胶的制备方法,如表1和表2所示。另外,还需说明的是,若抗菌抗氧化水凝胶不含单宁酸,则省略上述步骤(3)~(4),直接将步骤(2)的产物进行步骤(5)处理,得到水凝胶。The differences between Examples 1-9 and Comparative Examples 1-5 are compared and listed below through the list of ingredients and the table of preparation parameters. The specific preparation process can refer to the preparation method of the antibacterial and antioxidant hydrogel of the above-mentioned embodiment of the present invention, such as Table 1 and Table 2 are shown. In addition, it should be noted that if the antibacterial and antioxidant hydrogel does not contain tannic acid, the above steps (3) to (4) are omitted, and the product of step (2) is directly processed in step (5) to obtain water gel.
表1实施例1~9及对比例1~5的配料表The batching table of table 1
其中,实施例1~7及对比例1~5中的丙烯酰胺类单体采用丙烯酰胺;实施例8中的丙烯酰胺类单体为N-异丙基丙烯酰胺;实施例9中的丙烯酰胺类单体为N,N-双甲基丙烯酰胺。Wherein, the acrylamide monomer in Examples 1-7 and Comparative Examples 1-5 adopts acrylamide; the acrylamide monomer in Example 8 is N-isopropylacrylamide; the acrylamide in Example 9 The analogue monomer is N,N-bismethacrylamide.
表2实施例1~9及对比例1~5的制备参数表The preparation parameter table of table 2
以下对实施例1~5及对比例1~5的水凝胶进行性能测试:The performance test of the hydrogels of Examples 1-5 and Comparative Examples 1-5 is as follows:
一、透光率测试:用紫外-可见分光光度计在450~800nm波长范围内测量接触镜的透光率。1. Light transmittance test: measure the light transmittance of the contact lens with an ultraviolet-visible spectrophotometer in the wavelength range of 450-800nm.
二、力学性能测试:在室温和50%的湿度下,将水凝胶切成哑铃状(长16mm,宽4mm),利用万能试验机将拉伸速率固定为100mm/min,测试水凝胶接触镜的拉伸力学性能。2. Mechanical properties test: At room temperature and 50% humidity, cut the hydrogel into a dumbbell shape (length 16mm, width 4mm), use a universal testing machine to fix the tensile rate at 100mm/min, test the hydrogel contact The tensile mechanical properties of the mirror.
三、抗氧化性测试:将10mg水凝胶样品分别加入到30mL新鲜制备的1,1-二苯基-2-三硝基苯肼(DPPH·)或2,2’-连氮基-双-(3-乙基苯并二氢噻唑啉-6-磺酸)(ABTS·+)自由基溶液中,并分别将混合物在黑暗中保持1h或40min,然后利用紫外-可见分光光度计测量在517nm(DPPH·)或752nm(ABTS·+)处的吸光度。3. Antioxidant test: Add 10 mg of hydrogel sample to 30 mL of freshly prepared 1,1-diphenyl-2-trinitrophenylhydrazine (DPPH · ) or 2,2'-azino-bis -(3-Ethylbenzodihydrothiazoline-6-sulfonic acid) (ABTS ·+ ) free radical solution, and respectively keep the mixture in the dark for 1h or 40min, and then use the UV-Vis spectrophotometer to measure the Absorbance at 517nm (DPPH · ) or 752nm (ABTS ·+ ).
自由基清除率S计算如下:The free radical scavenging rate S was calculated as follows:
S=[1-Ai/Ac]*100%S=[1-A i /A c ]*100%
其中,Ai和Ac分别为混有水凝胶样品的自由基溶液和空白组自由基溶液在517nm或752nm处的吸光度。Wherein, A i and A c are the absorbance at 517nm or 752nm of the radical solution mixed with the hydrogel sample and the radical solution of the blank group, respectively.
四、抗菌性能测试:将样品灭菌后置于48孔板中,然后每孔加入200μL细菌悬液(1×105CFU/mL)。所选用的细菌为大肠杆菌(E.coli)或金黄色葡萄球菌(S.aureus)。在37℃的摇床中孵育8h后,将细菌接种在Luria-Bertani(LB)琼脂平板上,并在10倍连续稀释后进行细菌浓度计数。最后,根据孵育前后的菌落数计算相对细菌存活率。4. Antibacterial performance test: the samples were sterilized and placed in a 48-well plate, and then 200 μL of bacterial suspension (1×10 5 CFU/mL) was added to each well. The bacteria selected are Escherichia coli (E.coli) or Staphylococcus aureus (S.aureus). After incubation in a shaker at 37° C. for 8 h, the bacteria were inoculated on Luria-Bertani (LB) agar plates, and the bacterial concentration was counted after 10-fold serial dilution. Finally, relative bacterial survival was calculated based on the number of colonies before and after incubation.
五、体外细胞毒性实验:将人角膜上皮细胞(HCECs)置于Ham's F12完全培养基(含10%FBS)中增殖培养2~3天,然后以每孔1×104个细胞的浓度转移至96孔板中。继续培养24h后观察细胞粘附情况。当HCECs的生长密度达到90%后,将直径为4mm的水凝胶与细胞一起孵育10h。去除水凝胶后,将Cell Counting Kit-8(CCK-8)试剂加入孔板中,再孵育1~4h。最后,通过酶标仪测量450nm波长处的光密度(OD)值,可以间接定量活细胞的数量,反映细胞的活力。5. In vitro cytotoxicity test: human corneal epithelial cells (HCECs) were placed in Ham's F12 complete medium (containing 10% FBS) for proliferation and culture for 2 to 3 days, and then transferred to the in a 96-well plate. After continuing to culture for 24 h, the cell adhesion was observed. When the growth density of HCECs reached 90%, the hydrogel with a diameter of 4 mm was incubated with the cells for 10 h. After removing the hydrogel, add the Cell Counting Kit-8 (CCK-8) reagent into the well plate, and incubate for another 1-4 hours. Finally, by measuring the optical density (OD) value at a wavelength of 450nm with a microplate reader, the number of viable cells can be indirectly quantified and reflect the viability of the cells.
如图2所示,实施例1~5的水凝胶在可见光波长范围内的透光率均大于80%,证明实施例1~5的水凝胶具有良好的透光能力。As shown in FIG. 2 , the light transmittances of the hydrogels of Examples 1-5 in the visible light wavelength range are all greater than 80%, which proves that the hydrogels of Examples 1-5 have good light transmittance.
如图3所示,实施例1~5的水凝胶均具有良好的断裂伸长率和适中的拉伸强度。As shown in Figure 3, the hydrogels of Examples 1-5 all have good elongation at break and moderate tensile strength.
如图4所示,实施例1~5及对比例1~5的水凝胶均具有一定的抗氧化性,且抗氧化性均随单宁酸含量的增加而增强。As shown in FIG. 4 , the hydrogels of Examples 1-5 and Comparative Examples 1-5 all have certain oxidation resistance, and the oxidation resistance is enhanced with the increase of tannic acid content.
如图5所示,实施例1~5的水凝胶对金黄色葡萄球菌(S.aureus)及大肠杆菌(E.coli)均具有较好的抑菌能力,而对比例1~5的水凝胶不含季铵化壳聚糖,表现出较差的抗菌效果。As shown in Figure 5, the hydrogels of Examples 1-5 have good antibacterial ability to Staphylococcus aureus (S.aureus) and Escherichia coli (E.coli), while the water gels of Comparative Examples 1-5 Gels without quaternized chitosan exhibited poor antibacterial efficacy.
如图6所示,实施例1~5的水凝胶均具有一定的生物相容性,其人角膜上皮细胞的存活率分别为99%,95%,100%,82%,74%。As shown in FIG. 6 , the hydrogels of Examples 1-5 all have certain biocompatibility, and the survival rates of human corneal epithelial cells are 99%, 95%, 100%, 82%, and 74%, respectively.
通过上述实验结果表明,本发明各实施例的抗菌抗氧化水凝胶,尤其是实施例3的水凝胶,具有良好的透光率、一定的力学性能、较高的抗菌抗氧化能力以及优良的生物相容性,能够用作治疗细菌性角膜炎的水凝胶接触镜材料。The above experimental results show that the antibacterial and antioxidant hydrogels of the various embodiments of the present invention, especially the hydrogel of Example 3, have good light transmittance, certain mechanical properties, high antibacterial and antioxidant capabilities and excellent biocompatibility and can be used as a hydrogel contact lens material for the treatment of bacterial keratitis.
由于本发明方案实施例众多,各实施例实验数据庞大众多,不适合于此处逐一列举说明,但是各实施例所需要验证的内容和得到的最终结论均接近。故而此处不对各个实施例的验证内容进行逐一说明,仅以实施例1-5作为代表说明本发明申请优异之处。Due to the large number of embodiments of the present invention, the experimental data of each embodiment is huge and numerous, so it is not suitable to list and describe them one by one here, but the content to be verified and the final conclusion obtained by each embodiment are close. Therefore, the verification content of each embodiment will not be described one by one here, and only embodiments 1-5 are used as representatives to illustrate the advantages of the application of the present invention.
以上所述仅是对本发明的优选实施例及原理进行了详细说明,对本领域的普通技术人员而言,依据本发明提供的思想,在具体实施方式上会有改变之处,而这些改变也应视为本发明的保护范围。The above is only a detailed description of the preferred embodiments and principles of the present invention. For those of ordinary skill in the art, according to the ideas provided by the present invention, there will be changes in the specific implementation, and these changes should also be It is regarded as the protection scope of the present invention.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111549250.7A CN114381083B (en) | 2021-12-17 | 2021-12-17 | Antibacterial and antioxidant hydrogel for corneal contact lens and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111549250.7A CN114381083B (en) | 2021-12-17 | 2021-12-17 | Antibacterial and antioxidant hydrogel for corneal contact lens and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114381083A CN114381083A (en) | 2022-04-22 |
| CN114381083B true CN114381083B (en) | 2023-03-24 |
Family
ID=81197050
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111549250.7A Active CN114381083B (en) | 2021-12-17 | 2021-12-17 | Antibacterial and antioxidant hydrogel for corneal contact lens and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114381083B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116478331A (en) * | 2023-05-22 | 2023-07-25 | 南京工业大学 | Degradable antibacterial hydrogel and preparation method thereof |
| CN117304547A (en) * | 2023-09-14 | 2023-12-29 | 海南医学院第一附属医院 | Polyacrylamide-quaternized chitosan/EGCG hydrogel and its preparation method and application in back wound healing |
| CN118059297B (en) * | 2024-04-16 | 2024-07-12 | 中国科学技术大学 | Thermosensitive antibacterial hydrogel material and preparation method and application thereof |
| CN119119352B (en) * | 2024-06-21 | 2025-07-01 | 未目(上海)科技有限公司 | Soft hydrophilic contact lens material, soft hydrophilic contact lens, and preparation method and application thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1298502A (en) * | 2000-10-24 | 2002-05-06 | Bausch & Lomb | Prevention of bacterial attachment to biomaterials by cationic polysaccharides |
| RU2341539C9 (en) * | 2002-10-02 | 2009-08-20 | Колопласт А/С | Hydrogel |
| EP1934289A4 (en) * | 2005-09-09 | 2011-07-20 | Ottawa Health Research Inst | IPN ALLOYS AND ASSOCIATED METHODS AND COMPOSITIONS |
| JP5140757B2 (en) * | 2009-02-20 | 2013-02-13 | 株式会社シード | Drug sustained release hydrogel contact lens and drug release method using drug sustained release hydrogel contact lens |
| MX372729B (en) * | 2014-07-09 | 2020-04-23 | Lubrizol Advanced Mat Inc | HYDROGEL COMPOSITIONS |
| CN108563038A (en) * | 2018-04-23 | 2018-09-21 | 青岛高新区尚达医药研究所 | A kind of lubrication antimicrobial form contact lenses and preparation method thereof |
| CN111481735A (en) * | 2019-01-25 | 2020-08-04 | 华中科技大学同济医学院附属协和医院 | Medical antibacterial wound-protecting hydrogel dressing and preparation method thereof |
| JP2022538347A (en) * | 2019-06-27 | 2022-09-01 | レイヤーバイオ,インコーポレーテッド | Ophthalmic device delivery method and system |
| CN113336893B (en) * | 2021-06-07 | 2023-06-13 | 四川大学 | A kind of preparation method of antibacterial conductive adhesive hydrogel |
-
2021
- 2021-12-17 CN CN202111549250.7A patent/CN114381083B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN114381083A (en) | 2022-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114381083B (en) | Antibacterial and antioxidant hydrogel for corneal contact lens and preparation method thereof | |
| Jiao et al. | Drug-free contact lens based on quaternized chitosan and tannic acid for bacterial keratitis therapy and corneal repair | |
| Lei et al. | A synergy between dopamine and electrostatically bound bactericide in a poly (vinyl alcohol) hybrid hydrogel for treating infected wounds | |
| US20240350703A1 (en) | Tough antibacterial hydrogel dressing and preparation method thereof | |
| Hemmatgir et al. | Characterization of a novel semi-interpenetrating hydrogel network fabricated by polyethylene glycol diacrylate/polyvinyl alcohol/tragacanth gum as a wound dressing | |
| Dang et al. | Preparation, characterization, and evaluation of 3, 6-ON-acetylethylenediamine modified chitosan as potential antimicrobial wound dressing material | |
| Thomas et al. | Breathing‐in/breathing‐out approach to preparing nanosilver‐loaded hydrogels: highly efficient antibacterial nanocomposites | |
| Gonçalves et al. | Preparation and characterization of a novel antimicrobial film dressing for wound healing application | |
| CN110028614B (en) | Antibacterial micro-nano gel and fiber with protein adsorption function and preparation method thereof | |
| Boggione et al. | Preparation of polyvinyl alcohol hydrogel containing bacteriophage and its evaluation for potential use in the healing of skin wounds | |
| CN112795030B (en) | Drug-loaded anti-adhesion contact lens hydrogel material and preparation method thereof | |
| KR20190126405A (en) | Antibacterial Polymers and Antibacterial Hydrogels | |
| US20240277894A1 (en) | Composite antibacterial hydrogel dressing, preparation method and application thereof | |
| Kim et al. | Antioxidant and physical properties of dual-networked contact lenses containing quercetin using chitosan and alginate | |
| CN118059297B (en) | Thermosensitive antibacterial hydrogel material and preparation method and application thereof | |
| Ko et al. | Effect of ionic natural polysaccharides on the functional enhancement of porous hydrogel contact lenses | |
| Wang et al. | In situ construction of Ag NPs in bio-inspired multilayer films for long-term bactericidal and biofilm inhibition properties | |
| Liu et al. | Preparation of a nanocomposite hydrogel with high adhesion, toughness, and inherent antibacterial properties by a one-pot method | |
| CN114213570B (en) | Acid-sensitive antibacterial coating and preparation method and application thereof | |
| CN119371595A (en) | A kind of antibacterial and antioxidant dynamic nanogel and its preparation method and application | |
| Ferreira et al. | Synthesis and Characterization of Antibacterial Poly {2‐[(methacryloyloxy) ethyl] trimethylammonium Chloride}/Chitosan Semi‐Interpenetrating Networks for Papain Release | |
| Fang et al. | Light-degradable nanocomposite hydrogels for antibacterial wound dressing applications | |
| CN113384741A (en) | Quaternary ammonium salt polyphosphazene hydrogel wound dressing with active and passive dual antibacterial mechanisms and preparation method thereof | |
| CN116942890B (en) | Antibacterial anti-inflammatory thermosensitive hydrogel with function of promoting wound closure and preparation method thereof | |
| Deng et al. | Preparation and application of sodium alginate/PHMB/Ca 2+ high-strength and high-antibacterial hydrogel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |